Gastric Cancer
Conditions
Interventions
Treatment group:Oxaliplatin 130 mg/m2 intravenous infusion over 2 hours on Day 1
Tegafur capsules 40 mg/m2, taken orally twice daily after breakfast and dinner on Days 1-14
combined with Fuzi Lizhong Decoction treatment. Each treatment cycle consists of 21 days, with evaluation after two treatment cycles.
Control group:Oxaliplatin 130 mg/m2 intravenous infusion over 2 hours on Day 1
and Tegafur capsules 40 mg/m2, taken orally twice daily after breakfast and dinner, on Days 1-14.
Sponsors
Yichang Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
57 Years to 87 Years
Inclusion criteria
Inclusion criteria: The diagnostic criteria of Western medicine refer to the "Guidelines for the Diagnosis and Treatment of Gastric Cancer" (2022 Edition) by the Chinese Society of Clinical Oncology (CSCO) and the "Guidelines for Holistic Integrative Management of Cancer" (2022 Edition) by the Chinese Anti-Cancer Association (CACA).
Exclusion criteria
Exclusion criteria: Patients with other combined tumors; those with incomplete baseline data; those with psychological and/or mental disorders; those with ulcers, intestinal perforation, intestinal obstruction, or gastrointestinal bleeding; and those who are pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CEA; IL-6;CA724;CA242; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical Efficacy;TCM Syndrome Scoring;Recent Therapeutic Effect;Karnofsky Performance Status Score; | — |
Countries
China
Contacts
Public ContactWei Zhang
Yichang Traditional Chinese Medicine Hospital
Outcome results
None listed